Dr. Richard Kevin Gilroy, MD

Dr. Gilroy practices at Mountain West Endoscopy Center in Salt Lake City, Utah.

Dr. Gilroy's NPI, 1255389060, was assigned on May 4, 2006. Dr. Gilroy holds Utah license 9692229-1205.

Dr. Gilroy's primary practice is Mountain West Endoscopy Center, at 6360 South 3000 East, Suite 320, Salt Lake City, UT 84121. The practice phone is (801) 944-3166.

Dr. Gilroy's primary practice is Mountain West Endoscopy Center in Salt Lake City, Utah. Dr. Gilroy is also affiliated with St. Mark's Hospital. The medical group on file is Utah Gastroenterology. Dmand AI also links Dr. Gilroy to 4 more hospitals, 5 medical groups and 4 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gilroy practices, 10 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Gilroy's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Gilroy is licensed in Utah.

CMS data shows 441 Medicare services from Dr. Gilroy across 4 procedure codes in 2024, for 422 Medicare patients. Medicare paid $11,130 for them.

CMS counts 422 Medicare patients who saw Dr. Gilroy in 2024. The largest group is 65 to 74, with 242 patients. 74% of them have high blood pressure, and 70% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.82, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gilroy's median patient age at 57, with 49% women.

In 2024, Dr. Gilroy wrote 581 Medicare Part D claims for 144 patients. 83% of them were for generic drugs. CMS names the drug for 365 of them, across 13 drugs with 11 or more claims each, at $167,069 in total drug cost. In 2023, CMS named 347 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Gilroy for performance year 2024, reported as part of a group. Dr. Gilroy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 33 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Gilroy, more than 57% of the clinicians it reports for that procedure.

Dmand AI links Dr. Gilroy to 2 clinical trials. Conditions studied include Colitis, Ulcerative and Colitis. Eli Lilly and Company sponsors the most, 2. Open Payments lists research payments to Dr. Gilroy that name 2 trials.

CMS Open Payments shows 393 general payments to Dr. Gilroy from 29 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Gilead Sciences, Inc. paid the most, $123,296. It also lists 4 research payments totaling $1,260 from 2018 to 2020, naming 2 clinical trials.